The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.50
Bid: 29.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.448%)
Open: 29.50
High: 29.50
Low: 29.50
Prev. Close: 29.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bonus Share Options, Exercise of Options & TVR

13 Sep 2019 07:00

RNS Number : 1929M
Ilika plc
13 September 2019
 

Ilika plc

("Ilika" or the "Company")

 

Award of Bonus Share Options, Exercise of Options and Total Voting Rights

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces the grant, to executive directors of nominal value options over 331,947 ordinary shares of 1p each in the Company.

 

The options represent in aggregate 0.33% per cent of the existing issued share capital.

 

The options were awarded as part of the company's bonus scheme where 50% is payable as cash and 50% is deferred into options for one year, subject to continued employment.

 

The executive directors are each exercising nominal value options, previously awarded, over 20,000 ordinary shares of 1p each in the company.

 

Accordingly, the Company has applied to the London Stock Exchange for 60,000 ordinary shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00am on 17 September 2019.

 

Following Admission, the Company's issued share capital will comprise 100,778,600 ordinary shares of 1p each and may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury. 

 

 Director

Number of options granted

Number of options

Exercised

Total number of Options now held

Per cent. of current issued share capital

Graeme Purdy

207,229

20,000

2,510,816

2.49%

Brian Hayden

60,896

20,000

1,334,501

1.32%

Steve Boydell

63,822

20,000

662,490

0.66%

 

Graeme Purdy, Chief Executive, holds 754,427 Ordinary shares representing 0.75% of current issued share capital and Steve Boydell, Finance Director, holds 32,000 Ordinary shares representing 0.03% of current issued share capital. Brian Hayden, Chief Scientific Officer holds 20,000 Ordinary shares representing 0.02% current issued share capital and 426,300 Preference Shares.

 

 

 

 

Details of the full notifications received by the Company are set out below:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Graeme Purdy

2

Reason for the notification

 

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Ilika plc

b)

LEI

213800TMDNIE3Z8XXD26

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

 

 

Identification code

GB00B608Z994

 

 

 

b)

Nature of the transaction

 

a) Grant of bonus share options

b) Exercise of options

c)

 

Price(s) and volume(s)

 

 

a)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

207,229

 

 

 

 

 

 

 

 

b)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

20,000

 

 

 

 

 

 

 

 

d)

 

Aggregated information

 

 

n/a

- Aggregated volume

 

 

 

- Price

 

 

 

 

e)

Date of the transaction

12.09.19

f)

Place of the transaction

Off market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Brian Hayden

2

Reason for the notification

 

a)

Position/status

Chief Scientific Officer

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Ilika plc

b)

LEI

213800TMDNIE3Z8XXD26

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

 

 

Identification code

GB00B608Z994

 

 

b)

Nature of the transaction

 

 

a) Grant of bonus share options

b) Exercise of options

c)

 

Price(s) and volume(s)

 

 

a)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

60,896

 

 

 

 

 

 

 

 

b)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

20,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

n/a

- Aggregated volume

 

 

 

- Price

 

 

 

e)

Date of the transaction

12.09.19

f)

Place of the transaction

Off market

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Steve Boydell

2

Reason for the notification

 

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Ilika plc

b)

LEI

213800TMDNIE3Z8XXD26

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

 

 

Identification code

GB00B608Z994

 

 

b)

Nature of the transaction

 

 

a) Grant of bonus share options

b) Exercise of options

c)

 

Price(s) and volume(s)

 

 

a)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

63,822

 

 

 

 

 

 

 

 

b)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

20,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

n/a

 

 

- Price

 

 

 

e)

Date of the transaction

12.09.19

f)

Place of the transaction

Off market

 

 

 

For more information contact:

 

Ilika plc

 

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan, William Hall

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

 

 

Note:

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain. If you have any queries on this, then please contact Steve Boydell, Finance Director of the Company (responsible for arranging release of this announcement) on 023 8011 1400.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCQLLFFKKFXBBF
Date   Source Headline
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.